The Lancet: Most commonly prescribed glaucoma drug reduces risk of vision loss by more than 50% over 2 years
This item is under embargo and is only visible to journalists
Please login here
Regions: Europe, United Kingdom
Keywords: Health, Medical
The item has been withdrawn. If you are a journalists please contact the person that posted the item with any questions.